1,1'-BIS-[[2,3,6-TRI-O-ACETYL-4-O-(2',3',4',6'-TETRA-O-ACETYL-BETA-D-GALACTOPYRANOSYL)-BETA-D-GLUCOPYRANOSYL]-THIOMETHYL]-FERROCENE
Compound with spectra: 1 NMR
![1,1'-BIS-[[2,3,6-TRI-O-ACETYL-4-O-(2',3',4',6'-TETRA-O-ACETYL-BETA-D-GALACTOPYRANOSYL)-BETA-D-GLUCOPYRANOSYL]-THIOMETHYL]-FERROCENE](/api/compound/od3DZ6aslV.png?ph=true&h=300&w=458 "1,1'-BIS-[[2,3,6-TRI-O-ACETYL-4-O-(2',3',4',6'-TETRA-O-ACETYL-BETA-D-GALACTOPYRANOSYL)-BETA-D-GLUCOPYRANOSYL]-THIOMETHYL]-FERROCENE")
| SpectraBase Compound ID | od3DZ6aslV |
|---|---|
| InChI | InChI=1S/2C32H37O17S.Fe/c2*1-15(33)40-12-23-25(42-17(3)35)27(43-18(4)36)29(45-20(6)38)31(47-23)49-26-24(13-41-16(2)34)48-32(50-14-22-10-8-9-11-22)30(46-21(7)39)28(26)44-19(5)37;/h2*23-32H,12-14H2,1-7H3;/t23-,24+,25+,26+,27+,28-,29-,30+,31+,32-;23-,24-,25+,26-,27+,28+,29-,30-,31+,32+;/m01./s1 |
| InChIKey | OVCQJPWKXCRWKF-LHUVUORWSA-N |
| Mol Weight | 1507.2 g/mol |
| Molecular Formula | C64H74FeO34S2 |
| Exact Mass | 1506.285228 g/mol |
| Enantiomer InChIKey | OVCQJPWKXCRWKF-YWWDGABRSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
6H,13H-5,13:6,12-Dietheno-5a,12a-(methaniminomethano)-1H,5H,8H,12H-[1,2,4]triazolo[1,2-a][1,2,4]triazolo[1',2':1,2]pyridazino[4,5-d]pyridazine-18-acetic acid, 2,3,9,10-tetrahydro-.alpha.-(2-methylpropyl)-1,3,8,10,17,19-hexaoxo-2,9-diphenyl-, hexyl ester, stereoisomer
Quamoclin II peracetate[(S)-Convolvulinoic acid 11-O.beta,-D-glucopyranosyl-(1-3)-O-[4-O-2(S)-methylbutyryl-.alpha.,L-rhamnopyranosyl-(1-4)]-O-(2-O-n-dodececanoyl).alpha.,L-rhamnopyranosyl-(1-4)-O-.alpha.-L-rhymnopyranosyl[-(1-2)-.beta.D-fucopyranoside peracetate]
Quamoclin I peracetate [(S)-Convolvulinoic acid 11-O.beta,-D-glucopyranosyl-(1-3)-O-[4-O-2(S)-methylbutyryl-.alpha.,L-rhamnopyranosyl-(1-4)]-O-(2-O-n-dodececanoyl).alpha.,L-rhamnopyranosyl-(1-4)-O-.alpha.-L-rhymnopyranosyl[-(1-2)-.beta.D-fucopyranoside peracetate]
Dispiro[piperidine-4,2'-[7,14,24,31]tetraoxapentacyclo[30.2.2.23,6.215,18.220,23]dotetraconta[3,5,15,17,20,22,32,34,35,37,39,41]dodecaen e-19',4''-piperidine], 1,1''-diacetyl-5',33'-dibromo-16',22',36',37',40',41'-hexamethyl-
13',16':18',21'-dietheno-1,1''-diethyl-3',14',20',31'-tetramethyldispiro[piperidine-4,17'-[5,12,22,29]tetraoxa[37,40,41]triazatetracyclo[31.13.1.0.(4,45).0(30,35)]heptatetraconta-1',3',13',15',18',20',30',34',35',45'-decaene-47',4''-piperidine]-38',42'-dione
41,42,43,44,45,46,47,48-Octamethoxy-4,9,14,19,24,29,34,39-octamethylnonacyclo[35.3.1.1(2,6).1(7,11).1(12,16).1(17,21).1(22,26).1(27,31).1(32,36)]octatetraconta-1(41),2,4,6(48),7,9,11(47),12,14,16(46),17,19,21(45),22,24,26(44),27,29,31(43),32,34,36(42),37,39-tetracosaene
(2S,5S,7S,9S,10S,12R,13Z,15R)-9-[(1S,2R*)-1-Ethyl-2-hydroxybutyl]-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyltetrahydropyran-2-yl]-15-(4-methoxybenzyloxy)-2,10,12-trimethyl-1,6,8-trioxodispiro[4.1.5.3]pentadec-13-ene
N-[4-((2-chloro-4-sulfophenyl){3-methyl-4-[(3-sulfobenzyl)amino]phenyl}methylene)-2-methyl-2,5-cyclohexadien-1-ylidene](3-sulfophenyl)methanaminium trihydrogen [(trioxotungstato)(trioxomolybdato)phosphate]
(2S,5S,7S,9S,10S,12R,13R*,14R*)-9-[(1S,2R*)-1-Ethyl-2-hydroxybutyl]-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyltetrahydropyran-2-yl]-15-(4-methoxybenzyloxy)-2,10,12-trimethyl-1,6,8-trioxodispiro[4.1.5.3]pentadecan-13,14-diol
4H,6H,15H,17H-Tetrapyrano[2,3-f:2',3'-f':2'',3''-h:2''',3'''-h']cyclo buta[1,2-c:4,3-c']bis[1]benzopyran-4,17-dione, 10,10a,10b,11,20c,20d-hexahydro-2,6,6,10,10,11,11,15,15,19-decamethyl-, [10aS-(10a.alpha.,10b.beta.,20c.beta.,20d.alpha.)]-
| Title | Journal or Book | Year |
|---|---|---|
| Convenient Methods for the Synthesis of Ferrocene−Carbohydrate Conjugates | Organic Letters | 2004 |